Doravirine/Islatravir is a combination of two medications used to treat HIV-1 infection. Doravirine helps to block the virus from multiplying in the body, while Islatravir works by interfering with the virus’s ability to reproduce. Together, they help to lower the amount of HIV in the blood, which can improve the immune system and reduce the risk of developing HIV-related illnesses.

Bictegravir/Emtricitabine/Tenofovir Alafenamide is another combination medication used in the treatment of HIV-1 infection. Bictegravir helps to prevent the virus from multiplying, while Emtricitabine and Tenofovir Alafenamide work by blocking the virus’s ability to reproduce. This combination helps to reduce the amount of HIV in the blood, supporting the immune system and decreasing the likelihood of HIV-related health issues.

HIV-1 Infection – Human Immunodeficiency Virus type 1 (HIV-1) infection is a viral condition that targets the immune system, specifically the CD4+ T-cells, which are crucial for immune response. The virus replicates within these cells, leading to their gradual depletion. As the infection progresses, the immune system becomes increasingly compromised, making the body more susceptible to opportunistic infections and certain cancers. The progression of HIV-1 infection can vary, but without intervention, it typically advances through stages, starting from acute infection to chronic infection, and eventually to acquired immunodeficiency syndrome (AIDS). During the chronic phase, the virus continues to multiply at lower levels, often without symptoms, but it can still be transmitted to others. Over time, the persistent viral activity and immune system damage can lead to significant health issues.